Free Trial

Acrivon Therapeutics (ACRV) SEC Filings & 10K Form

Acrivon Therapeutics logo
$1.16 +0.01 (+0.43%)
As of 11:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Acrivon Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
4:24 PM
Acrivon Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
3:47 PM
Acrivon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2025
3:16 PM
Acrivon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
7:21 PM
Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
6:07 PM
Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
6:26 PM
Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2025
7:34 AM
Acrivon Therapeutics (Filer)
Form ARS
04/25/2025
7:30 AM
Acrivon Therapeutics (Filer)
Form DEF 14A
04/25/2025
7:32 AM
Acrivon Therapeutics (Filer)
Form DEFA14A
04/21/2025
3:22 PM
Acrivon Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
3:32 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:28 PM
Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
3:30 PM
Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:08 AM
Acrivon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2025
3:48 PM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
4:15 PM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
3:44 PM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
4:36 PM
Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:28 PM
Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:31 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:52 PM
Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:53 PM
Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:54 PM
Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:55 PM
Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:59 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:04 PM
Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:06 PM
Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:08 PM
Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:10 PM
Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:11 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:06 AM
Acrivon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:22 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
7:00 AM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
5:49 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
5:43 AM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:52 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:53 PM
Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:00 AM
Acrivon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:36 AM
Acrivon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
3:20 PM
Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
07/10/2024
7:29 PM
Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
Form SC 13G/A
07/10/2024
7:34 PM
Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
Form SC 13G/A
06/24/2024
4:36 PM
Acrivon Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:26 PM
Acrivon Therapeutics (Issuer)
BAUM CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:27 PM
Acrivon Therapeutics (Issuer)
DiRocco Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:27 PM
Acrivon Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:28 PM
Acrivon Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ACRV) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners